Lung Adenocarcinoma — Research

Lung Adenocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	17,778	`("Adenocarcinoma of Lung"[mh] OR "Adenocarcinoma, Lung"[mh] OR "Adenocarcinomas, Lung"[mh])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	7,869	`("Adenocarcinoma of Lung"[mh] OR "Adenocarcinoma, Lung"[mh] OR "Adenocarcinomas, Lung"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	1,393	`("Adenocarcinoma of Lung"[mh] OR "Adenocarcinoma, Lung"[mh] OR "Adenocarcinomas, Lung"[mh]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (98)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 98 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
· Ann Oncol · 2017 · PMID 28950338 · validated civic_curation pubmed
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.
· Lung Cancer · 2022 · PMID 35245845 · validated civic_curation pubmed
A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case Report.
· Onco Targets Ther · 2021 · PMID 34163176 · validated civic_curation pubmed
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.